Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms.

Yuan X, Dong Y, Tsurushita N, Tso JY, Fu W.

JCI Insight. 2018 Jan 25;3(2). pii: 96600. doi: 10.1172/jci.insight.96600. [Epub ahead of print]

2.

Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.

Hartman TE, Sar N, Genereux K, Barritt DS, He Y, Burky JE, Wesson MC, Tso JY, Tsurushita N, Zhou W, Sauer PW.

Biotechnol Bioeng. 2007 Feb 1;96(2):294-306.

PMID:
16897745
3.

Paravertebral transcutaneous electrical nerve stimulation reduces movement during general anesthesia with isoflurane.

Su HP, Tso JY, Chen YS, Chen TY, Shiau JM, Tseng CC.

Anesth Analg. 2006 Jun;102(6):1765-7.

PMID:
16717323
4.

Engineered human IgG antibodies with longer serum half-lives in primates.

Hinton PR, Johlfs MG, Xiong JM, Hanestad K, Ong KC, Bullock C, Keller S, Tang MT, Tso JY, Vásquez M, Tsurushita N.

J Biol Chem. 2004 Feb 20;279(8):6213-6. Epub 2003 Dec 29.

5.

Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells.

Mone AP, Huang P, Pelicano H, Cheney CM, Green JM, Tso JY, Johnson AJ, Jefferson S, Lin TS, Byrd JC.

Blood. 2004 Mar 1;103(5):1846-54. Epub 2003 Nov 20.

6.

Humanization and characterization of the anti-HLA-DR antibody 1D10.

Kostelny SA, Link BK, Tso JY, Vasquez M, Jorgensen BH, Wang H, Hall WC, Weiner GJ.

Int J Cancer. 2001 Aug 15;93(4):556-65.

7.
8.

Generation of partial agonist ligands of the T-cell receptor by engineering of antibodies against CD3.

Chau LA, Tso JY, Madrenas J.

Transplant Proc. 2001 Feb-Mar;33(1-2):528-9. No abstract available.

PMID:
11266941
9.

IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.

Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.

Cancer Res. 2000 Dec 15;60(24):6977-84.

10.

Non-FcR-binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo.

Carpenter PA, Tso JY, Press OW, Yu X, Anasetti C.

Transplant Proc. 2000 Nov;32(7):1545-6. No abstract available.

PMID:
11119827
11.

Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells.

Carpenter PA, Pavlovic S, Tso JY, Press OW, Gooley T, Yu XZ, Anasetti C.

J Immunol. 2000 Dec 1;165(11):6205-13.

12.

HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.

Cole MS, Stellrecht KE, Shi JD, Homola M, Hsu DH, Anasetti C, Vasquez M, Tso JY.

Transplantation. 1999 Aug 27;68(4):563-71.

PMID:
10480417
13.
14.
15.

Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.

Cole MS, Anasetti C, Tso JY.

J Immunol. 1997 Oct 1;159(7):3613-21.

PMID:
9317161
16.

Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation.

Pilson RS, Levin W, Desai B, Reik LM, Lin P, Korkmaz-Duffy E, Campbell E, Tso JY, Kerwin JA, Hakimi J.

J Immunol. 1997 Aug 1;159(3):1543-56.

PMID:
9233654
17.

Signals through CD8 or CD4 can induce commitment to the CD4 lineage in the thymus.

Bommhardt U, Cole MS, Tso JY, Zamoyska R.

Eur J Immunol. 1997 May;27(5):1152-63.

PMID:
9174605
18.

Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy.

Smith JA, Tso JY, Clark MR, Cole MS, Bluestone JA.

J Exp Med. 1997 Apr 21;185(8):1413-22.

19.

Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide.

Yu XZ, Zhu L, Davis JE, Tso JY, Hansen JA, Anasetti C.

J Immunol. 1996 Oct 15;157(8):3420-9.

PMID:
8871640
20.

Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters.

Asmuth DM, Olson RD, Hackett SP, Bryant AE, Tweten RK, Tso JY, Zollman T, Stevens DL.

J Infect Dis. 1995 Nov;172(5):1317-23.

PMID:
7594670
21.

Preparation of a bispecific F(ab')2 targeted to the human IL-2 receptor.

Tso JY, Wang SL, Levin W, Hakimi J.

J Hematother. 1995 Oct;4(5):389-94.

PMID:
8581374
22.
23.

A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma.

Bakács T, Lee J, Moreno MB, Zacharchuk CM, Cole MS, Tso JY, Paik CH, Ward JM, Segal DM.

Int Immunol. 1995 Jun;7(6):947-55.

PMID:
7577803
24.

Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo.

Moreno MB, Titus JA, Cole MS, Tso JY, Le N, Paik CH, Bakács T, Zacharchuk CM, Segal DM, Wunderlich JR.

Cancer Immunol Immunother. 1995 Mar;40(3):182-90.

PMID:
7728777
25.

The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy.

Weiner GJ, Kostelny SA, Hillstrom JR, Cole MS, Link BK, Wang SL, Tso JY.

J Immunol. 1994 Mar 1;152(5):2385-92.

PMID:
8133049
26.

Construction of a human Ig combinatorial library from genomic V segments and synthetic CDR3 fragments.

Akamatsu Y, Cole MS, Tso JY, Tsurushita N.

J Immunol. 1993 Nov 1;151(9):4651-9.

PMID:
8409426
27.

Formation of a bispecific antibody by the use of leucine zippers.

Kostelny SA, Cole MS, Tso JY.

J Immunol. 1992 Mar 1;148(5):1547-53.

PMID:
1531669
28.

A recombinant, membrane-acting immunotoxin.

Chovnick A, Schneider WP, Tso JY, Queen C, Chang CN.

Cancer Res. 1991 Jan 15;51(2):465-7.

29.

Expression of functional Xenopus TFIIIA in Escherichia coli.

Tso JY, Siebel C, Korn LJ.

Nucleic Acids Res. 1989 Mar 11;17(5):2145. No abstract available.

31.
32.

Early replication and expression of oocyte-type 5S RNA genes in a Xenopus somatic cell line carrying a translocation.

Guinta DR, Tso JY, Narayanswami S, Hamkalo BA, Korn LJ.

Proc Natl Acad Sci U S A. 1986 Jul;83(14):5150-4.

33.

Structure of the gene for Xenopus transcription factor TFIIIA.

Tso JY, Van Den Berg DJ, Korn LJ.

Nucleic Acids Res. 1986 Mar 11;14(5):2187-200.

34.
35.
36.

Synthesis of human insulin gene. VIII. Construction of expression vectors for fused proinsulin production in Escherichia coli.

Guo LH, Stepień PP, Tso JY, Brousseau R, Narang S, Thomas DY, Wu R.

Gene. 1984 Jul-Aug;29(1-2):251-4.

PMID:
6092228
38.

Nucleotide sequence of Escherichia coli purF and deduced amino acid sequence of glutamine phosphoribosylpyrophosphate amidotransferase.

Tso JY, Zalkin H, van Cleemput M, Yanofsky C, Smith JM.

J Biol Chem. 1982 Apr 10;257(7):3525-31.

39.

Chemical modifications of Serratia marcescens anthranilate synthase component I.

Tso JY, Zalkin H.

J Biol Chem. 1981 Oct 10;256(19):9901-8.

41.

Primary structure of Serratia marcescens anthranilate synthase component II.

Tso JY, Hermodson MA, Zalkin H.

J Biol Chem. 1980 Feb 25;255(4):1451-7.

Supplemental Content

Support Center